Mark Molitch
Endocrinology, Diabetes & Metabolism · Chicago, ILNPI 1255365490
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $42,815 of the $52,573 with a category attached, or 81.4%. It is spread thinly across 15 manufacturers, the largest accounting for just 17.4%. Reporting peaked in 2024 at $16,620 and has fallen 83.9% since, to $2,682 in 2025. Among endocrinology, diabetes & metabolism clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $1222.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$9K
- Novo Nordisk$8K
- Lexicon Pharmaceuticals, Inc.$7K
- Merck$6K
- Amgen$5K
- Janssen Scientific Affairs, LLC$4K
- plus $12K from 9 others
Across 15 payments — averaging $4439.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Strongbridge US Inc.$30K
- Sanofi US Services Inc.$27K
- Xeris Pharmaceuticals, Inc.$5K
- Novartis$5K
What the payments were for
- Consulting fees$42,81581%
- Speaking & faculty fees$7,00513%
- Travel & lodging$1,6933%
- Food & beverage$1,0592%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $9,140 |
| Novo Nordisk | 4 | $8,365 |
| Lexicon Pharmaceuticals, Inc. | 5 | $7,395 |
| Merck | 11 | $5,984 |
| Amgen | 1 | $5,200 |
| Janssen Scientific Affairs, LLC | 1 | $4,000 |
| Amryt Pharma Holdings Ltd | 5 | $3,522 |
| Recordati_rare_diseases_inc. | 1 | $2,750 |
| Xeris Pharmaceuticals, Inc. | 1 | $1,800 |
| Chiesi USA, Inc. | 3 | $1,565 |
| Chiasma, Inc. | 1 | $1,150 |
| OPKO Pharmaceuticals, LLC | 1 | $1,000 |
| Gilead | 1 | $440 |
| Corcept Therapeutics | 3 | $244 |
| Lilly USA, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,573 in reported general payments places this provider in the 90th percentile of 347 endocrinology, diabetes & metabolism providers in Illinois.
See all endocrinology, diabetes & metabolism providers in Illinois →
Other endocrinology, diabetes & metabolism in Chicago
- Wahid KassarChicago$884K
- George BakrisChicago$403K
- Wenyu HuangChicago$341K
- Silvana PannainChicago$226K
- Grazia AleppoChicago$162K
- Tamara VokesChicago$139K
- Emily SmithChicago$112K
- Antonio BiancoChicago$111K
- Aaron BenjaminChicago$105K
- David OyerChicago$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.